The Value of Permixon in Benign Prostatic Hypertrophy
- 1 February 1986
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 58 (1), 36-40
- https://doi.org/10.1111/j.1464-410x.1986.tb05424.x
Abstract
A double-blind trial comparing the effect of Permixon (160 mg bd) against placebo in the treatment of benign prostatic hypertrophy is described. In both groups a significant improvement in flow rate and subjective assessment of symptoms was seen. There was no significant difference between the results of treatment in either group.This publication has 5 references indexed in Scilit:
- Effects of Prazosin in Patients with Benign Prostatic ObstructionJournal of Urology, 1983
- Ineffectiveness of phenoxybenzamine in treatment of benign prostatic hypertrophy A controlled studyUrology, 1983
- Assessment of the Antihypercholesterolemic Drug, Probucol, in Benign Prostatic HyperplasiaJournal of Urology, 1983
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- The Effect of Adrenergic Blocking Drugs on Outflow ResistanceBritish Journal of Urology, 1975